EULAR 2026

INGELHEIM, Germany, June 18, 2026 Boehringer Ingelheim has announced new long-term survival modeling analyses from its pivotal Phase III...

SHANGHAI and HONG KONG, China, June 8, 2026 Antengene Corporation Limited announced the presentation of the first preclinical data...

WALTHAM, Mass., June 2, 2026 Zenas BioPharma, Inc. announced positive results from its registrational Phase 3 INDIGO trial evaluating...

AMSTERDAM, Netherlands, June 3, 2026 argenx presented new clinical data at the European Alliance of Associations for Rheumatology (EULAR)...

SANDWICH, UK, June 3, 2026 Levicept Ltd announced new data from its Phase 2 clinical trial of LEVI-04, a...

LONDON, United Kingdom, June 3, 2026 Johnson & Johnson has announced positive late-breaking results from its Phase 2 JASMINE...

SOUTH SAN FRANCISCO, California, USA, June 3, 2026 IDEAYA Biosciences and Roche have entered into a strategic clinical collaboration...

SHANGHAI, China, June 3, 2026 Antengene has announced the first preclinical data for ATG-207, its investigational αCD3-TGF-β bifunctional fusion...

BASEL, Switzerland, June 1, 2026 Novartis announced that it will present new data from 31 abstracts across its expanding...

BRUSSELS, Belgium, May 19, 2026 UCB announced new Phase 3b clinical data showing that BIMZELX® (bimekizumab) demonstrated superior efficacy...